{
  "id": 17141119,
  "title": "Kestra Medical Technologies CFO Vaseem Mahboob sells $2.4M in shares",
  "url": "https://urgent.news/2026/10/29/kestra-medical-technologies-cfo-vaseem-mahboob-sells-2-4m-in-shares",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-29T23:16:02.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/kestra-medical-technologies-cfo-vaseem-mahboob-sells-24m-in-shares-93CH-4985578"
  },
  "original_language": "en",
  "account": "Chief Financial Officer Vaseem Mahboob of Kestra Medical Technologies sold shares worth around $2.41 million over three days from October 27 to October 29, 2026. These shares, totaling 79,500, were sold at prices between $30.00 and $31.04 per share. The sale came as the stock traded near its 52-week high of $31.04 following a 57% increase over six months. However, InvestingPro analysis suggests the stock is overvalued relative to its Fair Value. At the same time, Mahboob bought back shares through options, acquiring 79,500 shares at $17.00 per share, amounting to $1.35 million. These options, part of the same trading plan, have an exercise date of March 6, 2035. Post these transactions, Mahboob owns 60,609 Kestra shares directly and holds 79,500 options. Kestra Medical reported a 60% year-over-year revenue surge in Q1 2026 to $31 million, but also posted a larger-than-expected loss of $0.75 per share. The company raised its full-year revenue guidance to $141 million and improved its gross margin to 56.5%. Analysts from firms like Stifel, Piper Sandler, and Evercore ISI have expressed optimism about Kestra's prospects, citing strong growth, a solid gross margin, and the potential of its ASSURE technology.",
  "summary": null,
  "key_points": [
    "CFO Vaseem Mahboob sold $2.4M in Kestra shares over three days in October 2026",
    "Stock reached 52-week high of $31.04 after 57% six-month increase",
    "Mahboob bought 79,500 shares via options at $17.00 each, totaling $1.35M"
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}